Mechanism of Enhanced Oral Absorption of a Nano-Drug Delivery System Loaded with Trimethyl Chitosan Derivatives

Introduction In the previous study, nanoparticles coated with trimethyl chitosan (TMC) derivatives (PPTT-NPs) could promote the oral bioavailability of panax notoginseng saponins (PNS). Herein, we chose PPTT-NPs as a model drug to study the property and mechanism of intestinal absorption in vitro and in vivo. Methods The stability of PPTT-NPs was evaluated using simulated gastric fluid and simulated intestinal fluid. The uptake and transport of PPTT-NPs were investigated in Caco-2 and Caco-2&HT29 co-culture cells. The biosafety, intestinal permeability, adhesion, and absorption mechanism of PPTT-NPs were investigated using SD rats in vivo. The live imaging and biodistribution of PPTT-NPs were observed by IVIS. Furthermore, the effects on CYP3A4 of PPTT-NPs were investigated using testosterone as the probe substrate. Results The results of the stability assay showed that PPTT-NPs had a strong tolerance to the pH and digestive enzymes in the gastrointestinal environment. In vitro cell experiments showed that the uptake of drugs exhibited a time-dependent. When the ratio of TMC-VB12 and TMC-Cys was 1:3, the uptake capacity of PPTT-NPs was the highest. PPTT-NPs could enhance the paracellular transport of drugs by reversibly opening a tight junction. Animal experiments demonstrated that PPTT-NPs have good biological safety. PPTT-NPs had good adhesion and permeability to small intestinal mucosa. Meanwhile, PPTT-NPs needed energy and various protein to participate in the uptake of drugs. The live imaging of NPs illustrated that PPTT-NPs could prolong the residence time in the intestine. Moreover, TMC-VB12 and TMC-Cys could reduce the metabolism of drugs by inhibiting CYP3A4 to a certain extent. Conclusion The results show that TMC-VB12 and TMC-Cys are effective in the transport of PPTT-NPs. PPTT-NPs can increase the intestinal adhesion of drugs and exert high permeation by intestinal enterocytes which demonstrate significant and efficient potential for oral delivery of the BCS III drugs.

[1]  Yaling Shi,et al.  Preparation and in vitro and in vivo evaluation of Panax notoginseng saponins-loaded nanoparticles coated with Trimethyl Chitosan derivatives. , 2021, Journal of pharmaceutical sciences.

[2]  Zhenhai Zhang,et al.  Preparation and Evaluation of Lecithin/Zein Hybrid Nanoparticles for the Oral Delivery of Panax Notoginseng Saponins. , 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  L. Tang,et al.  [Changes of guanylate cyclase C in colon tissues of rats with intestinal injury associated with severe acute pancreatitis]. , 2021, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[4]  Wei Wu,et al.  Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route , 2021, Acta pharmaceutica Sinica. B.

[5]  Yun Fang,et al.  Bioavailability and antioxidant activity of nanotechnology-based botanic antioxidants. , 2021, Journal of food science.

[6]  Mitali H Patel,et al.  Surface modified polymeric nanoparticles for drug delivery: preparation and applications. , 2020, Recent patents on drug delivery & formulation.

[7]  Mitali H Patel,et al.  Preparation and Surface Modification of Polymeric Nanoparticles for Drug Delivery: State of the Art , 2020 .

[8]  Chun‐Xia Zhao,et al.  Development of High-Drug-Loading Nanoparticles. , 2020, ChemPlusChem.

[9]  N. Okur,et al.  Challenges in oral drug delivery and applications of lipid nanoparticles as potent oral drug carriers for managing cardiovascular risk factors. , 2020, Current pharmaceutical biotechnology.

[10]  Jian Shen,et al.  Design and investigation of penetrating mechanism of octaarginine-modified alginate nanoparticles for improving intestinal insulin delivery. , 2020, Journal of pharmaceutical sciences.

[11]  E. Perucca,et al.  Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications , 2020, CNS Drugs.

[12]  Min Wang,et al.  Evaluation of Intestinal Absorption Mechanism and Pharmacokinetics of Curcumin-Loaded Galactosylated Albumin Nanoparticles , 2019, International journal of nanomedicine.

[13]  S. Bossmann,et al.  Nano-inspired Technologies for Peptide Delivery. , 2019, Current protein & peptide science.

[14]  Farzad Seidi,et al.  Emulsion Techniques for the Production of Pharmacological Nanoparticles. , 2019, Macromolecular bioscience.

[15]  Shu-jun Cao,et al.  Nanoparticles: Oral Delivery for Protein and Peptide Drugs , 2019, AAPS PharmSciTech.

[16]  Jingying Liu,et al.  SEDDS for intestinal absorption of insulin: Application of Caco‐2 and Caco‐2/HT29 co‐culture monolayers and intra‐jejunal instillation in rats , 2019, International journal of pharmaceutics.

[17]  Mehran Alavi,et al.  Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles , 2019, Drug metabolism and personalized therapy.

[18]  Chenguang Liu,et al.  Biocompatibility Profile and In Vitro Cellular Uptake of Self-assembled Alginate Nanoparticles , 2019, Molecules.

[19]  M. Banach,et al.  Application of nanotechnology to improve the therapeutic benefits of statins. , 2019, Drug discovery today.

[20]  Sanyog Jain,et al.  Drug–Lipid Conjugates for Enhanced Oral Drug Delivery , 2019, AAPS PharmSciTech.

[21]  N. Erdoğar,et al.  Nanocapsules for Drug Delivery: An Updated Review of the Last Decade. , 2019, Recent patents on drug delivery & formulation.

[22]  Beibei Yan,et al.  Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs. , 2018, Current drug delivery.

[23]  Christel A. S. Bergström,et al.  Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations , 2018, Pharmaceutical Research.

[24]  K. Landfester,et al.  The challenges of oral drug delivery via nanocarriers , 2018, Drug delivery.

[25]  N. Meng,et al.  Recent Progress of Nano-drug Delivery System for Liver Cancer Treatment. , 2017, Anti-cancer agents in medicinal chemistry.

[26]  Z. Zuo,et al.  A Review of Food–Drug Interactions on Oral Drug Absorption , 2017, Drugs.

[27]  Jingnan Wang,et al.  Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy , 2017, Journal of Nanobiotechnology.

[28]  A. Ungell,et al.  Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions , 2017, Biopharmaceutics & drug disposition.

[29]  M. Oshimura,et al.  Development of Caco-2 cells co-expressing CYP3A4 and NADPH-cytochrome P450 reductase using a human artificial chromosome for the prediction of intestinal extraction ratio of CYP3A4 substrates. , 2017, Drug metabolism and pharmacokinetics.

[30]  Q. Ping,et al.  Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. , 2016, International journal of pharmaceutics.

[31]  Mahmoud M Abd-Elwakil,et al.  Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery. , 2016, Current pharmaceutical design.

[32]  A. Bernkop‐Schnürch,et al.  Mucus permeating thiomer nanoparticles. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  Cuifang Cai,et al.  VB12-coated Gel-Core-SLN containing insulin: Another way to improve oral absorption. , 2015, International journal of pharmaceutics.

[34]  Y. Sugiyama,et al.  Use of a Physiologically Based Pharmacokinetic Model for Quantitative Prediction of Drug-Drug Interactions via CYP3A4 and Estimation of the Intestinal Availability of CYP3A4 Substrates. , 2015, Journal of pharmaceutical sciences.

[35]  S. Guterres,et al.  Improving drug biological effects by encapsulation into polymeric nanocapsules. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[36]  Jingbo Liu,et al.  Optimization of Caco-2 and HT29 co-culture in vitro cell models for permeability studies , 2015, International journal of food sciences and nutrition.

[37]  Nurunnabi,et al.  Oral absorption mechanism and anti-angiogenesis effect of taurocholic acid-linked heparin-docetaxel conjugates. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Lei Zhang,et al.  Ex vivo and in situ approaches used to study intestinal absorption. , 2013, Journal of pharmacological and toxicological methods.

[39]  Hong Yuan,et al.  Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. , 2013, Molecular pharmaceutics.

[40]  Aki T Heikkinen,et al.  Modelling of drug disposition kinetics in in vitro intestinal absorption cell models. , 2010, Basic & clinical pharmacology & toxicology.

[41]  R. V. van Breemen,et al.  Caco-2 cell permeability assays to measure drug absorption , 2005, Expert opinion on drug metabolism & toxicology.

[42]  K. Usmani,et al.  Human Cytochrome P450: Metabolism of Testosterone by CYP3A4 and Inhibition by Ketoconazole , 2004, Current protocols in toxicology.

[43]  C. Papp-Jámbor,et al.  [Cytochrome P450 enzymes and their role in drug interactions]. , 2002, Der Anaesthesist.

[44]  C. Papp-Jámbor,et al.  Cytochrom-P450-Enzyme und ihre Bedeutung für Medikamenteninteraktionen , 2002, Der Anaesthesist.